AHLA The Fundamentals of Life Sciences Law: Drugs, Devices, and Biotech (Non-Members)
Select a format
Select subscription type
Terms & conditions
One Year Subscription Only Terms
Subscribers receive the product(s) listed on the Order Form and any Updates made available during the annual subscription period. Shipping and handling fees are not included in the annual price.
Subscribers are advised of the number of Updates that were made to the particular publication the prior year. The number of Updates may vary due to developments in the law and other publishing issues, but subscribers may use this as a rough estimate of future shipments. Subscribers may call Customer Support at 800-833-9844 for additional information.
Subscribers may cancel this subscription by: calling Customer Support at 800-833-9844; emailing firstname.lastname@example.org; or returning the invoice marked 'CANCEL'.
If subscribers cancel within 30 days after the product is ordered or received and return the product at their expense, then they will receive a full credit of the price for the annual subscription.
If subscribers cancel between 31 and 60 days after the invoice date and return the product at their expense, then they will receive a 5/6th credit of the price for the annual subscription. No credit will be given for cancellations more than 60 days after the invoice date. To receive any credit, subscriber must return all product(s) shipped during the year at their expense within the applicable cancellation period listed above.
View or download a free Sample Chapter of this product.
The Fundamentals of Life Sciences Law: Drugs, Devices, and Biotech, Second Edition, provides a solid grounding in the legal principles and issues inherent in this complex area. Both new practitioners and experienced attorneys alike will benefit from this unparalleled coverage.
This edition features contributions from some of the most experienced and respected practitioners of life sciences and health law. Whether you're looking for an introduction to this area, or you need a go-to reference on your shelf, the coverage includes:
- Regulation of Drugs
- Regulation of Medical Devices
- Regulation of Biologics
- Clinical Trials
- Fraud and Abuse
- Federal Agencies
- Regulation of Advertising, and Promotion of Drugs, Medical Devices, and Biologics
- State Regulation
- Intellectual Property
- Payment and Reimbursement
- International Issues
- Life Sciences Licensing Transaction
EDITOR IN CHIEF:
Kristian A. Werling
Jeremy Alexander, Lauren Battaglia, Brian A. Bohnenkamp, Nancy E. Bonifant, Eve M. Brunts, Elizabeth Carder-Thompson, Carl H. Coleman, Susan A. Edwards, Paige Fillingame, David C. Gibbons, Daniel G. Gottlieb, Eric S. Greig, Simone Handler-Hutchinson, Clinton D. Hermes, Stuart S. Kurlander, Robert F. Leibenluft, Vicki L. Lung, Melissa L. Markey, Juliet M. McBride, Leigh L. Oliver, Jordan Paradise, Heather H. Pierce, Jennifer L. Pike, Preeya Noronha Pinto, Kelly N. "Nikki" Reeves, Corey W. Roush, Thomas J. Quinlan, Jason W. Saspin, Richard B. Smith, Judith Toffenetti, Susan L. Walker, and Constance A. Wilkinson
Jeffrey W. Brennan, Stefanie Doebler, Jennifer S. Geetter, Scott A. Memmott, Stephen J. Smith Jr, and Heather M. Zimmerman
Published May, 2014.
eBooks, CDs, downloadable content, and software purchases are non-cancellable, nonrefundable and nonreturnable. Click here for more information about LexisNexis eBooks. The eBook versions of this title may feature links to Lexis+® for further legal research options. A valid subscription to Lexis+® is required to access this content.
Table of contents
Introduction/Preface/About the Editors and Authors
Chapter 1: Introduction to the Regulation of drugs
Chapter 2: Introduction to the regulation of Medical Devices
Chapter 3: Introduction to the Regulation of Biologics
Chapter 4: Regulation of Industry- Sponsored Clinical Trials
Chapter 5: Key Federal Agencies: Roles and Responsibilities
Chapter 6: Regulation of Advertising, Promotion, and Distribution of Drugs, Medical Devices and Biologics
Chapter 7: Life Sciences: Fraud and Abuse
Chapter 8: Antitrust Issues
Chapter 9: Privacy Issues
Chapter 10: State Regulation
Chapter 11: Intellectual Property
Chapter 12: Payment and Reimbursement Issues
Chapter 13: International Issues
Chapter 14: Life Sciences Transactions and Licensing